ACET

2.17011.79%
DH

Donald Healey

Chief Technology Officer

Dr. Donald Healey, also known as Don, PhD serves as the Chief Technology Officer at Adicet Bio, Inc. since October 26, 2020. He served as Chief Scientific Officer of Opexa Therapeutics, Inc from April 2013 to February 2017 and served as its Vice President of Scientific Development since April 2010. Dr. Healey served as Director of Immunology at Argos Therapeutics, a North Carolina based cell Therapy Company developing personalized immunotherapeutic cell therapy products for the treatment of cancer and infectious disease. From February 2017 to October 2020, Dr. Healey served as the Senior Vice President, Operations and Site Head for KBI Biopharma, Inc. From March 2001 to April 2010, Dr. Healey held various positions at Argos Therapeutics, Incorporated and ML Laboratories. Previously from 2001 to 2003 he was Group Leader at ML Laboratories (formerly Cobra Therapeutics, Ltd.) in the United Kingdom where he managed all clinical and preclinical cell therapy development programs. He has been an invited lecturer in immunology at numerous universities, authored numerous publications and is listed on several patent applications. He was a member of the Council of the British Society for Immunology from 1996-1998 and held post-doctoral positions in the Department of Pathology, Cambridge University, UK, conducting studies on immunoregulation in animal models of autoimmunity, including Type I Diabetes and Multiple Sclerosis. Dr. Healey received his Ph.D. from University of London and holds a B.Sc. in Cellular Pathology from Bristol University.

Positions